期刊文献+

左炔诺孕酮宫内缓释系统治疗难治性功能失调性子宫出血患者的临床观察 被引量:20

原文传递
导出
摘要 目的探讨左炔诺孕酮宫内缓释系统(ING-IUS,即曼月乐)治疗顽固性功能失调性子宫出血患者的临床疗效。方法对65例顽固性功能失调性子宫出血患者放置ING-IUS,放置前、放置后1、3、6、12个月均进行月经量测定、血红蛋白水平检测、经阴道超声检测子宫内膜厚度。结果放置ING-IUS后患者月经量明显减少(P<0.05),血红蛋白水平升高(P<0.05),子宫内膜厚度下降(P<0.05),并持续菲薄状态。结论 ING-IUS治疗顽固性功能失调性子宫出血可以明显减少月经量,纠正贫血、提高血红蛋白水平,可有效抑制子宫内膜增生。
出处 《中国妇幼保健》 CAS 2016年第3期656-657,共2页 Maternal and Child Health Care of China
  • 相关文献

参考文献8

  • 1Higham JM,O'Brien PM,Shaw RW.Assessment of menstrual blood loss using a pictorial chart[J].Br J Obstet Gynecol,2010,97(8):734-739.
  • 2Tu X,Huang G,Tan S.Chinese herbal medicine for dysfunctional uterine bleeding:a meta-analysis[J].Evid Based Complement Alternat Med,2009,6(1):99-105.
  • 3王锦.功能失调性子宫出血的临床治疗观察[J].吉林医学,2010,31(3):343-344. 被引量:25
  • 4邓姗,郎景和.左炔诺孕酮宫内缓释系统的临床功用及相关基础研究[J].国外医学(妇产科学分册),2004,31(5):285-288. 被引量:148
  • 5Stewart A,Cummins C,Gold L,et al.The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia:a systematic review[J].Br J Obstet Gynecol,2013,108(1):74-86.
  • 6Hurskainen R,Teperi J,Rissanen P,et al.Clinical outcomes and costs with the levonorgestrel-relesing intrauterine system or hysterectomy for treatment of menorrhagia:randomized trial 5-year followup[J].JAMA,2004,291(12):1456-1463.
  • 7Matteson KA,Rahn DD,Wheeler TL,et al.Nonsurgical management of heavy menstrual bleeding:a systematic review[J].Obstet Gynecol,2013,121(3):632-643.
  • 8Jondet M,Letellier B,Verdys MT.Endometrial vascularization in levonorgestrel intrauterine device users:computerized microvessel measurement study[J].Contraception,2008,71(1):60-64.

二级参考文献25

  • 1Rutanen EM. Endometrial response to intrauterine release of levonorgestrel. Gynecol Forum, 1998, 3(1): 11-14.
  • 2Luukkainen T, Pakarinen P, Toivonen J. Progestin-releasing intrauterine system. Semi Reprod Med, 2001, 19(4): 355-363.
  • 3Zalel Y, Shulman A, Lidor A, et al. The local progestational efffect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study. Hum Reprod, 2002, 17(11):2878-2880.
  • 4Guillebaud .I. The levnorgestrel intrauterine systemL: a clinical perspective from the UK. Ann N Y Acad Sci, 2003, 997(2): 185-193.
  • 5Backman T, Huhtala S, Luoto R, et al. Advance information improves improves user satisfaction with the levonorgestrel intrauterine system.Obstet Gynecol, 2002, 99(4): 608-613.
  • 6French R, Cowan F, Mansour D, et al. Hormonally impregnated intrauterine systems(IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy. Cochrane Database Syst Rev, 2001,(2):CD001776.
  • 7Backman T, Rauramo I, Huhtala S, et al. Pregancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol, 2004, 190(1):50-54.
  • 8Roy SN, Bhattacharya S. Benefits and risks of pharmacological agents used for the treatment of menorrhagia. Drug Saf, 2004, 27(2):75-90.
  • 9Xiao BL, Wu SC, Chong J, et al. Therapeutic effects of the lenonorgestrelrelesing intrauterina system in the treatment of idiopathic menorrhagia. Fertil Steril, 2003, 79(4):963-969.
  • 10Barrington JW, Arunkalivanan AS, Avdek-Fattah M. Compariso between the levonorgestrel intrauterine system (LNG-IUS)and thermal balloon ablation in the treatment of menorrhagia. Eur J Obstet Gynecol Reprod Biol, 2003, 108(1):72-74.

共引文献171

同被引文献175

引证文献20

二级引证文献264

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部